Cargando…

Prognostic factors in Polish patients with BRCA1-dependent ovarian cancer

BACKGROUND: Treatment outcomes appear to be better for ovarian cancer (OC) patients carrying the BRCA1/2 germline mutation than for patients with sporadic OC. However, most published data are for North American, British and Jewish populations. There have been very few studies on treatment outcomes i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szatkowski, Wiktor, Blecharz, Paweł, Mituś, Jerzy W., Jasiówka, Marek, Łuczyńska, Elżbieta, Jakubowicz, Jerzy, Byrski, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724399/ https://www.ncbi.nlm.nih.gov/pubmed/26807161 http://dx.doi.org/10.1186/s13053-015-0041-2

Ejemplares similares

Methods and results of local treatment of brain metastases in patients with breast cancer
por: Szadurska, Agnieszka, et al.
Publicado: (2017)

Pathological complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
por: Byrski, Tomasz, et al.
Publicado: (2015)

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
por: Łukomska, Alicja, et al.
Publicado: (2021)

Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland
por: Wojcik, P., et al.
Publicado: (2016)

Methods and results of locoregional treatment of brain metastases in patients with non-small cell lung cancer
por: Patla, Anna, et al.
Publicado: (2016)

Comparison between Breast MRI and Contrast-Enhanced Spectral Mammography
por: Łuczyńska, Elżbieta, et al.
Publicado: (2015)

Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients
por: Luczynska, Elzbieta, et al.
Publicado: (2014)

Metaplastic breast cancer with rapidly progressive recurrence in a young woman: case report and review of the literature
por: Mituś, Jerzy W., et al.
Publicado: (2016)

Systemic treatment of non-small cell lung cancer brain metastases
por: Cedrych, Ida, et al.
Publicado: (2016)

Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism
por: Jakubowska, Anna, et al.
Publicado: (2008)

Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast
por: Mituś, J. W., et al.
Publicado: (2015)

Changes in the clinical characteristics, treatment options, and therapy outcomes in patients with phyllodes tumor of the breast during 55 years of experience
por: Mituś, Jerzy Władysław, et al.
Publicado: (2013)

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer
por: Byrski, Tomasz, et al.
Publicado: (2012)

Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results
por: Łuczyńska, Elżbieta, et al.
Publicado: (2016)

New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
por: Kluska, Anna, et al.
Publicado: (2015)

A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet
por: Huzarski, Tomasz, et al.
Publicado: (2006)

Post-Irradiation Bladder Syndrome After Radiotherapy of Malignant Neoplasm of Small Pelvis Organs: An Observational, Non-Interventional Clinical Study Assessing VESIcare(®)/Solifenacin Treatment Results
por: Jaszczyński, Janusz, et al.
Publicado: (2016)

Contrast-Enhanced Spectral Mammography: Comparison with Conventional Mammography and Histopathology in 152 Women
por: Luczyńska, Elzbieta, et al.
Publicado: (2014)

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
por: Ogrodniczak, Alicja, et al.
Publicado: (2022)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
por: Byrski, T, et al.
Publicado: (2012)

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
por: Byrski, T, et al.
Publicado: (2012)

Postoperative irradiation in patients with pT3-4N0 laryngeal cancer: results and prognostic factors
por: Skóra, Tomasz, et al.
Publicado: (2014)

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
por: Byrski, T, et al.
Publicado: (2011)

Correlation between CT Perfusion and Clinico-Pathological Features in Prostate Cancer: A Prospective Study
por: Łuczyńska, Elżbieta, et al.
Publicado: (2015)

The Utility of Diffusion Weighted Imaging (DWI) Using Apparent Diffusion Coefficient (ADC) Values in Discriminating Between Prostate Cancer and Normal Tissue
por: Łuczyńska, Elżbieta, et al.
Publicado: (2014)

The intraoperative assessment of the effectiveness of computed tomography in the detection of the residual mass of the retroperitoneal space in patients with nonseminoma testicular tumors after chemotherapy
por: Jaszczyński, Janusz, et al.
Publicado: (2011)

Prevalence of the most frequent BRCA1 mutations in Polish population
por: Brozek, Izabela, et al.
Publicado: (2011)

Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland
por: Olszanecka-Glinianowicz, Magdalena, et al.
Publicado: (2023)

Cisplatin in breast cancer treatment in BRCA1 carriers
por: Gronwald, Jacek, et al.
Publicado: (2012)

Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival
por: Biglia, Nicoletta, et al.
Publicado: (2016)

Metabolic syndrome – a new definition and management guidelines: A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
por: Dobrowolski, Piotr, et al.
Publicado: (2022)

BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study
por: Kowalik, Artur, et al.
Publicado: (2018)

Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers
por: Domagala, Pawel, et al.
Publicado: (2016)

DArT-based evaluation of soybean germplasm from Polish Gene Bank
por: Czembor, Elzbieta, et al.
Publicado: (2021)

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
por: Kluz, Tomasz, et al.
Publicado: (2018)

Transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin, for patients with invasive bladder cancer – clinical outcome
por: Nowak-Sadzikowska, Jadwiga, et al.
Publicado: (2013)

Coverage of the Genetic Background of Breast Cancer in the Polish Population
por: Serrano-Fernández, Pablo, et al.
Publicado: (2006)

Mercury, Fatty Acids Content and Lipid Quality Indexes in Muscles of Freshwater and Marine Fish on the Polish Market. Risk Assessment of Fish Consumption
por: Łuczyńska, Joanna, et al.
Publicado: (2017)

Total Mercury and Fatty Acids in Selected Fish Species on the Polish Market: A Risk to Human Health
por: Łuczyńska, Joanna, et al.
Publicado: (2022)

Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families
por: Dębniak, Tadeusz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0lq07jf7h8q0dniouagp3mumud